Dr. Timos Papagatsias’ Post

Thoughts on this? >> Ionis touts PhII MASH study data that feature its DGAT2 antisense inhibitor >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #pharmaceutical #healthcare #biotech #pharma

Thoughts on this? >> NS Pharma's Duchenne muscular dystrophy drug Viltepso flunks Phase 3 confirmatory trial >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #biotech #pharma #productmarketing #pharmaceutical

Immunovant plans multiple trials for FcRn inhibitor based on PhI data to compete with argenx, J&J >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #pharma #productmarketing #biotech #pharmaceutical

Immunovant plans multiple trials for FcRn inhibitor based on PhI data to compete with argenx, J&J >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #pharma #biotech #productmarketing #pharmaceutical

Amgen’s MariTide to be tested in multiple obesity-related indications at PhIII >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #pharmaceutical #pharma #biotech #healthcare

Thoughts on this? >> #ASCO24: BMS details confirmatory trial win for KRAS inhibitor Krazati >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #healthcare #biotech #pharmaceutical #productmarketing

Thoughts on this? >> Cardurion touts Ph2 data for PDE9 inhibitor in heart failure, plans for two more trials >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #pharmaceutical #pharma #productmarketing #biotech

Thoughts on this? >> NS Pharma's Duchenne muscular dystrophy drug Viltepso flunks Phase 3 confirmatory trial >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #pharma #pharmaceutical #healthcare #biotech

The novelty, complexity and evolving regulatory guidance of oligonucleotide (oligo) therapies can create greater technical challenges for drug development than conventional drugs, but the right laboratory partner and technology can alleviate those challenges. Learn how to tackle the challenges of metabolite profiling and identification for oligo drug development. #MetID #oligonucleotide #Drugdevelopment https://hubs.li/Q027Lw-m0

Thoughts on this? >> Cardurion touts Ph2 data for PDE9 inhibitor in heart failure, plans for two more trials >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #pharma #productmarketing #biotech #healthcare